Related Experiment Video
Updated: Mar 9, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Topical imiquimod clears invasive melanoma
Brittany E Grady1, James M Spencer2
1DeBusk College of Osteopathic Medicine, Lincoln Memorial University, Harrogate, Tennessee, USA.
Abstract:
Malignant melanoma has continually shown a pattern of increased incidence and mortality in the last 50 years. Currently, wide local excision is the mainstay of treatment of primary cutaneous melanomas. Imiquimod has been shown to clear cases of melanoma in situ, but its role in the treatment of invasive cutaneous melanomas is unknown. We present the case of a patient who achieved complete histologic clearance of invasive melanoma following treatment with topical imiquimod.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy

